| Filed On | Filing |
|---|---|
| 14 Nov 2022 |
8-K/A: Results of Operations and Financial Condition
HILLSIDE, NEW JERSEY (November 10, 2022) - Integrated BioPharma, Inc. (OTCQX: INBP) (the “Company” or “INBP”) reports its financial results for the quarter ended September 30, 2022. |
| 03 Oct 2003 | 8-K/A: Financial Statements and Exhibits |
| 25 Apr 2003 | 8-K/A: Financial Statements and Exhibits |
| 06 Jan 1997 | 8-K/A: Changes in Registrant's Certifying Accountant |
| 13 Dec 1996 | 8-K/A: Changes in Registrant's Certifying Accountant |
| 13 Dec 1996 | 8-K/A: Changes in Registrant's Certifying Accountant |
Loading...
